Cargando…

OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves

Strains of Shiga toxin-producing Escherichia coli (STEC) can cause the severe Hemolytic Uremic Syndrome (HUS). Shiga toxins are protein toxins that bind and kill microvascular cells, damaging vital organs. No specific therapeutics or vaccines have been licensed for use in humans yet. The most common...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fingermann, Matias, Avila, Lucía, De Marco, Maria Belén, Vázquez, Luciana, Di Biase, Darío Nicolás, Müller, Andrea Verónica, Lescano, Mirta, Dokmetjian, José Christian, Fernández Castillo, Sonsire, Pérez Quiñoy, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183318/ https://www.ncbi.nlm.nih.gov/pubmed/29923791 http://dx.doi.org/10.1080/21645515.2018.1490381

Ejemplares similares

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation
por: Castillo, Sonsire Fernández, et al.
Publicado: (2016)

Characterization of Shiga toxin – producing Escherichia coli infections in beef feeder calves and the effectiveness of a prebiotic in alleviating Shiga toxin - producing Escherichia coli infections
por: Baines, Danica, et al.
Publicado: (2013)

Immune Maturation Effects on Viral Neutralization and Avidity of Hyperimmunized Equine Anti-SARS-CoV-2 Sera
por: González Viacava, Myriam Belén, et al.
Publicado: (2022)

Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
por: Grandi, Alberto, et al.
Publicado: (2023)

Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
por: Grandi, Alberto, et al.
Publicado: (2023)

Functionalization of OMVs for Biocatalytic Applications
por: Amalia, Lita, et al.
Publicado: (2023)

Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens
por: Croia, Lorenzo, et al.
Publicado: (2023)

Characterization of Shiga toxin-producing Escherichia coli (STEC) in feces of healthy and diarrheic calves in Urmia region, Iran
por: Dastmalchi, Saei H, et al.
Publicado: (2012)

Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
por: Carr, Warner W., et al.
Publicado: (2021)

Roles of Shiga Toxins in Immunopathology
por: Lee, Moo-Seung, et al.
Publicado: (2019)

Protection against Shiga Toxins
por: Kavaliauskiene, Simona, et al.
Publicado: (2017)

Shiga Toxins as Antitumor Tools
por: Robert, Aude, et al.
Publicado: (2021)

Phylogenetic analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease outbreaks
por: Lee, James E, et al.
Publicado: (2007)

Purification and Characterization of Shiga Toxin 2f, an Immunologically Unrelated Subtype of Shiga Toxin 2
por: Skinner, Craig, et al.
Publicado: (2013)

Do the A Subunits Contribute to the Differences in the Toxicity of Shiga Toxin 1 and Shiga Toxin 2?
por: Basu, Debaleena, et al.
Publicado: (2015)

Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli
por: Baranzoni, Gian Marco, et al.
Publicado: (2016)

Contribution of cropland to the spread of Shiga toxin phages and the emergence of new Shiga toxin-producing strains
por: Quirós, Pablo, et al.
Publicado: (2017)

The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS
por: Feitz, Wouter J. C., et al.
Publicado: (2021)

Isolation of Shiga toxin-producing Escherichia coli harboring variant Shiga toxin genes from seafood
por: Prakasan, Sreepriya, et al.
Publicado: (2018)

Serogroups, subtypes and virulence factors of shiga toxin-producing Escherichia coli isolated from human, calves and goats in Kerman, Iran
por: Taghadosi, Rohollah, et al.
Publicado: (2018)

PREPARATION AND PROPERTIES OF SHIGA TOXIN AND TOXOID
por: Dubos, René J., et al.
Publicado: (1946)

TOXINS AND ANTITOXINS OF BACILLUS DYSENTERIÆ SHIGA
por: Olitsky, Peter K., et al.
Publicado: (1920)

SEPARATION OF THE TOXINS OF BACILLUS DYSENTERIÆ SHIGA
por: McCartney, James E., et al.
Publicado: (1923)

STUDIES ON THE TOXIN PRODUCTION OF THE SHIGA BACILLI
por: Waaler, Erik
Publicado: (1936)

Shiga Toxin Binding to Glycolipids and Glycans
por: Gallegos, Karen M., et al.
Publicado: (2012)

Shiga Toxin Therapeutics: Beyond Neutralization
por: Hall, Gregory, et al.
Publicado: (2017)

Mechanism of Shiga Toxin Clustering on Membranes
por: Pezeshkian, Weria, et al.
Publicado: (2016)

Editorial: Shiga Toxin-Converting Bacteriophages
por: Węgrzyn, Grzegorz, et al.
Publicado: (2021)

Safety and Immunogenicity of a Chimeric Subunit Vaccine against Shiga Toxin-Producing Escherichia coli in Pregnant Cows
por: Vidal, Roberto M., et al.
Publicado: (2023)

Breaking the bilayer: OMV formation during environmental transitions
por: Bonnington, Katherine E., et al.
Publicado: (2017)

OMV Vaccines and the Role of TLR Agonists in Immune Response
por: Mancini, Francesca, et al.
Publicado: (2020)

Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage
por: Landoni, Verónica Inés, et al.
Publicado: (2022)

A Poly-N-Acetylglucosamine−Shiga Toxin Broad-Spectrum Conjugate Vaccine for Shiga Toxin-Producing Escherichia coli
por: Lu, Xi, et al.
Publicado: (2014)

Shiga toxin 2 translocation across intestinal epithelium is linked to virulence of Shiga toxin-producing Escherichia coli in humans
por: Tran, Seav-Ly, et al.
Publicado: (2018)

Rapid and quantitative detection of Shiga toxin1 and Shiga toxin2 based on multiple targets UPT‐LF assay
por: Wei, Qiaozhen, et al.
Publicado: (2020)

Identification, Shiga toxin subtypes and prevalence of minor serogroups of Shiga toxin-producing Escherichia coli in feedlot cattle feces
por: Capps, Kaylen M., et al.
Publicado: (2021)

Genomic Characterization of Two Shiga Toxin–Converting Bacteriophages Induced From Environmental Shiga Toxin–Producing Escherichia coli
por: Zhang, Yujie, et al.
Publicado: (2021)

Characteristics of Bacteriophage Isolates and Expression of Shiga Toxin Genes Transferred to Non Shiga Toxin-Producing E. coli by Transduction
por: Park, Da-Som, et al.
Publicado: (2021)

An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity
por: Norheim, Gunnstein, et al.
Publicado: (2015)

Shiga Toxin–producing Escherichia coli, Idaho
por: Lockary, Vivian Marie, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ej9k8b1bbnd1p02se668vesa5k